Healthcare News
Zepbound bests Wegovy for weight loss in new trial
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.
Early weight loss with tirzepatide predictive of larger cardiometabolic benefits later on
Tirzepatide confers significant weight loss and cardiometabolic benefits for patients with diabetes and overweight or obesity, especially for those who lose more weight earlier during treatment
Fasting, eating earlier in the day or eating fewer meals—what works best for weight loss?
Modifying your diet is important for managing obesity and preventing weight gain. This might include reducing your calorie intake, changing your eating patterns and prioritizing healthy food. But is one formula for weight loss more likely to result in success than another? Our new research compared three weight-loss methods, to see if one delivered more weight loss than the others.
Teens who had bariatric surgery maintain weight loss, diabetes remission 10 years later
A decade after receiving gastric bypass or sleeve gastrectomy as adolescents, many people maintain their weight loss and achieve remission of obesity-related conditions, including diabetes, according to a study.
The secret to slimming? Special 'skinny genes' double weight loss
The secret to losing weight could all be down to a combination of 14 "skinny genes," a new study has found.
